Literature DB >> 7211090

Plasma and urine free L-carnitine in human diabetes mellitus.

E De Palo, R Gatti, N Sicolo, D Padovan, R Vettor, G Federspil.   

Abstract

L-carnitine is essential for the transport of long-chain fatty acids into mitochondria and their oxidation. Recently, a relationship between plasma free fatty acids (FFA) and L-carnitine metabolism has been observed. Plasma free L-carnitine (FC), FFA, triglycerides, cholesterol, blood glucose concentration and daily excretion of FC were determined in 20 diabetic patients as well as in 18 control subjects. Both in male diabetics and in male controls, plasma FC was significantly higher than in females. Mean plasma FC was found to be significantly reduced in diabetics (21 +/- 2 vs 35 +/- 2 mumol/1 in non-diabetic subjects; p less than 0.005). Daily urinary excretion of FC was clearly lower in diabetic patients than in controls (172 +/- 34 vs 403 +/- 38 mumol/24 h; p less than 0.001). The reduced plasma FC in diabetes mellitus may be due to redistribution between circulating free and esterified carnitine and to increased utilization of FC for synthesis of acylcarnitine in tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7211090     DOI: 10.1007/bf02056110

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  14 in total

1.  Plasma and urine carnitine in diabetic ketosis.

Authors:  S M Genuth; C L Hoppel
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

2.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

3.  Carnitine levels in human serum in health and disease.

Authors:  T Böhmer; A Rydning; H E Solberg
Journal:  Clin Chim Acta       Date:  1974-11-20       Impact factor: 3.786

4.  Metabolism, turnover time, half life, body pool of carnitine-14C in normal, alloxan diabetic and insulin treated rats.

Authors:  M A Mehlman; M M Kader; D G Therriault
Journal:  Life Sci       Date:  1969-05-15       Impact factor: 5.037

5.  The effect of diet and development on blood levels of free and esterified carnitine in the rat.

Authors:  D W Seccombe; P Hahn
Journal:  Biochim Biophys Acta       Date:  1978-03-30

6.  Carnitine concentration in skeletal muscle tissue from patients with diabetes mellitus.

Authors:  G Cederblad; K Lundholm; T Scherstén
Journal:  Acta Med Scand       Date:  1977

7.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

8.  Urinary excretion of carnitine and serum concentrations of carnitine and lipids in patients with hypofunctional endocrine diseases: involvement of adrenocorticoid and thyroid hormones in ACTH-induced augmentation of carnitine and lipids metabolism.

Authors:  M Maebaski; N Kawamura; M Sato; A Imamura; K Yoshinaga
Journal:  Metabolism       Date:  1977-04       Impact factor: 8.694

9.  Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate.

Authors:  J Frohlich; D W Seccombe; P Hahn; P Dodek; I Hynie
Journal:  Metabolism       Date:  1978-05       Impact factor: 8.694

10.  Role of carnitine in hepatic ketogenesis.

Authors:  J D McGarry; C Robles-Valdes; D W Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  9 in total

1.  Effects of intravenous L-acetylcarnitine on retinal oscillatory potentials.

Authors:  W G Sannita; L Lopez; L Maggi; G Rosadini
Journal:  Doc Ophthalmol       Date:  1988-09       Impact factor: 2.379

Review 2.  Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2011-12-02       Impact factor: 5.614

3.  Obesity and lipid stress inhibit carnitine acetyltransferase activity.

Authors:  Sarah E Seiler; Ola J Martin; Robert C Noland; Dorothy H Slentz; Karen L DeBalsi; Olga R Ilkayeva; Jie An; Christopher B Newgard; Timothy R Koves; Deborah M Muoio
Journal:  J Lipid Res       Date:  2014-01-06       Impact factor: 5.922

4.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

5.  Carnitine deficiency as the possible etiology of idiopathic mitral valve prolapse: case study with speculative annotation.

Authors:  M Trivellato; E De Palo; R Gatti; A Parenti; M Piazza
Journal:  Tex Heart Inst J       Date:  1984-12

6.  Carnitine plasma concentrations in 353 metabolically healthy children.

Authors:  E Schmidt-Sommerfeld; D Werner; D Penn
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

7.  The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion.

Authors:  Aman Upadhyay; Kate E Boyle; Tom L Broderick
Journal:  Molecules       Date:  2021-11-15       Impact factor: 4.411

8.  Carnitine supplementation to obese Zucker rats prevents obesity-induced type II to type I muscle fiber transition and favors an oxidative phenotype of skeletal muscle.

Authors:  Aline Couturier; Robert Ringseis; Frank-Christoph Mooren; Karsten Krüger; Erika Most; Klaus Eder
Journal:  Nutr Metab (Lond)       Date:  2013-07-10       Impact factor: 4.169

9.  Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial.

Authors:  Yvonne Mh Bruls; Marlies de Ligt; Lucas Lindeboom; Esther Phielix; Bas Havekes; Gert Schaart; Esther Kornips; Joachim E Wildberger; Matthijs Kc Hesselink; Deborah Muoio; Patrick Schrauwen; Vera B Schrauwen-Hinderling
Journal:  EBioMedicine       Date:  2019-10-31       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.